2022 Pharma Training Courses from NSF

Published: 17-Jan-2022 Featured companies: NSF
Regulatory

Start your year right and keep your goals on track with NSF’s training and education. NSF's pharma training and education programs focus on changing behaviours at both an individual and organisation-wide level

All courses are interactive, with exercises, group discussions, breakout sessions and instructor-led interaction, resulting in engaging learning experiences.

Upcoming Courses

Pharmaceutical Formulation and Processing (Part 1) - QP Module
February 7-11

The Role & Professional Duties of the Qualified Person - QP Module
February 21-24

Advanced Therapy Medicinal Products
March 3

Pharmaceutical Formulation and Processing (Part 2) - QP Module
March 7-11 | In-person training

Certified Investigator Training
March 14-17

Our complete 2022 course list is online! View all courses >>

Featured companies

Founded in 1944, NSF’s mission is to protect and improve global human health. NSF, Pharmaceutical Services provides a comprehensive range of independent, third-party...
See more

You may also like

Regulatory

NSF International launches two water fitting accreditations

Read more
New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market

Trending Articles

  1. Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Syndax Pharmaceuticals' leukaemia drug Revuforj bags FDA approval The therapeutic is the first and only menin inhibitor to gain FDA approval for acute relapsed or refractory acute leukaemia
  4. AbbVie's Elahere approved for platinum-resistant ovarian cancer by the European Commission Elahere is the first FRα-targeting antibody-drug conjugate (ADC) to be approved in Europe for platinum-resistant ovarian cancer
  5. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Regulatory

NSF International launches two water fitting accreditations

New REG4 Accreditations to Help Water Fittings Suppliers Rapidly Deliver Products to Market
Regulatory

NSF explains why you might need a remediation program

The team at NSF explores why remediation projects are needed, the traits of successful programs and what to do to ensure success in your remediation efforts
Regulatory

Pharmaceutical legislation update subscription service

Sign up for NSF’s September start date
Manufacturing

Big names announced for leading Pharma and Cleanroom conference

The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Regulatory

White paper: Streamlining Pharma Operations in the Wake of COVID-19

COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris
Regulatory

Free webinar: Update on EMA and FDA’s approach to tackling drug shortages

The webinar will be hosted on 8 September, 2020 – 1pm BST
Regulatory

New edition of NSF’s Health Sciences Journal now live

The new Health Sciences Journal focuses on hope and optimism and is available to download
Subscribe now